Abstract | PURPOSE: EXPERIMENTAL DESIGN: In vitro and in vivo experiments examined the effect of vorinostat on the expression of NET, an uptake transporter for (131)I-MIBG. Human NB cell lines (Kelly and SH-SY-5Y) and NB1691-luc mouse xenografts were employed. The upregulated NET protein was characterized for its effect on (123)I-MIBG biodistribution. RESULTS: Preincubation of NB cell lines, Kelly, and SH-SY-5Y, with vorinostat caused dose-dependent increases in NET mRNA and protein levels. Accompanying this was a corresponding dose-dependent increase in MIBG uptake in NB cell lines. Four- and 2.5-fold increases were observed in Kelly and SH-SY-5Y cells, respectively, pretreated with vorinostat in comparison to untreated cells. Similarly, NB xenografts, created by intravenous tail vein injection of NB1691-luc, and harvested from nude mice livers treated with vorinostat (150 mg/kg i.p.) showed substantial increases in NET protein expression. Maximal effect of vorinostat pretreatment in NB xenografts on (123)I-MIBG biodistribution was observed in tumors that exhibited enhanced uptake in vorinostat-treated [0.062 ± 0.011 μCi/(mg tissue-dose injected)] vs. -untreated mice [0.022 ± 0.003 μCi/(mg tissue-dose injected); P < 0.05]. CONCLUSIONS: The results of our study provide preclinical evidence that vorinostat treatment can enhance NB therapy with (131)I-MIBG.
|
Authors | Swati S More, Melissa Itsara, Xiaodong Yang, Ethan G Geier, Michelle K Tadano, Youngho Seo, Henry F Vanbrocklin, William A Weiss, Sabine Mueller, Daphne A Haas-Kogan, Steven G Dubois, Katherine K Matthay, Kathleen M Giacomini |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 17
Issue 8
Pg. 2339-49
(Apr 15 2011)
ISSN: 1557-3265 [Electronic] United States |
PMID | 21421857
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | ©2011 AACR. |
Chemical References |
- Histone Deacetylase Inhibitors
- Hydroxamic Acids
- Norepinephrine Plasma Membrane Transport Proteins
- Radiopharmaceuticals
- 3-Iodobenzylguanidine
- Vorinostat
|
Topics |
- 3-Iodobenzylguanidine
(metabolism, pharmacokinetics)
- Animals
- Blotting, Western
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Dose-Response Relationship, Drug
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- HEK293 Cells
- Histone Deacetylase Inhibitors
(pharmacology)
- Humans
- Hydroxamic Acids
(pharmacology)
- Mice
- Mice, Nude
- Neoplasms, Experimental
(genetics, metabolism, pathology)
- Neuroblastoma
(genetics, metabolism, pathology)
- Norepinephrine Plasma Membrane Transport Proteins
(genetics, metabolism)
- Radiopharmaceuticals
(metabolism, pharmacokinetics)
- Reverse Transcriptase Polymerase Chain Reaction
- Tissue Distribution
(drug effects)
- Transplantation, Heterologous
- Vorinostat
|